Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.

[1]  Q. Tan,et al.  Evodiamine Induces G2/M Arrest and Apoptosis via Mitochondrial and Endoplasmic Reticulum Pathways in H446 and H1688 Human Small-Cell Lung Cancer Cells , 2014, PloS one.

[2]  M. D’hooghe,et al.  Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid-AZT conjugates. , 2014, Bioorganic & medicinal chemistry letters.

[3]  Yuan He,et al.  Synthesis of Novel Heterocyclic Ring‐Fused 18β‐Glycyrrhetinic Acid Derivatives with Antitumor and Antimetastatic Activity , 2014, Chemical biology & drug design.

[4]  R. Csuk Betulinic acid and its derivatives: a patent review (2008 – 2013) , 2014, Expert opinion on therapeutic patents.

[5]  Mingyao Liu,et al.  Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents. , 2014, European journal of medicinal chemistry.

[6]  Daniel J. Emmerich,et al.  Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment. , 2014, European journal of medicinal chemistry.

[7]  M. Hajdúch,et al.  Cytotoxic heterocyclic triterpenoids derived from betulin and betulinic acid. , 2012, Bioorganic & medicinal chemistry.

[8]  Mingyao Liu,et al.  Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption. , 2012, Journal of medicinal chemistry.

[9]  S. Safe,et al.  Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors , 2011, BMC Cancer.

[10]  D. Ströhl,et al.  Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. , 2010, European journal of medicinal chemistry.

[11]  Jia Li,et al.  Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. , 2009, Bioorganic & medicinal chemistry letters.

[12]  J. Thorson,et al.  Enhancing the divergent activities of betulinic acid via neoglycosylation. , 2009, Organic letters.

[13]  S. Shukla,et al.  Betulinic acid suppresses constitutive and TNFα‐induced NF‐κB activation and induces apoptosis in human prostate carcinoma PC‐3 cells , 2008, Molecular carcinogenesis.

[14]  Yusuke Yamamoto,et al.  RPN2 gene confers docetaxel resistance in breast cancer , 2008, Nature Medicine.

[15]  R. Freshney ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein , 2007, British Journal of Cancer.

[16]  J. Medema,et al.  Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. , 2007, Cancer letters.

[17]  W. Lee,et al.  Human ACAT-1 and ACAT-2 inhibitory activities of pentacyclic triterpenes from the leaves of Lycopus lucidus TURCZ. , 2006, Biological & pharmaceutical bulletin.

[18]  Perumal Yogeeswari,et al.  Betulinic acid and its derivatives: a review on their biological properties. , 2005, Current medicinal chemistry.

[19]  I. Jeremias,et al.  Betulinic acid-induced apoptosis in leukemia cells , 2004, Leukemia.

[20]  R. Supino,et al.  Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. , 2002, Cancer letters.

[21]  J. Eberle,et al.  The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. , 2001, The Journal of investigative dermatology.

[22]  J. Slupsky,et al.  Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha. , 2000, Molecular pharmacology.

[23]  I. Jeremias,et al.  Betulinic acid: A new cytotoxic agent against malignant brain‐tumor cells , 1999, International journal of cancer.

[24]  I. Jeremias,et al.  Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors , 1999, Klinische Padiatrie.

[25]  J. Dichgans,et al.  Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. , 1999, The Journal of pharmacology and experimental therapeutics.

[26]  M. Peter,et al.  Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid* , 1998, The Journal of Biological Chemistry.

[27]  K. Lee,et al.  Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. , 1997, Bioorganic & medicinal chemistry.

[28]  Geoffrey A. Cordell,et al.  Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis , 1995, Nature Medicine.

[29]  M. Bentley,et al.  Betulin and lupeol in bark from four white-barked birches , 1988 .